Type 2 diabetes linked to increased risk for Parkinson’sMarch 17, 2021Movement DisordersParkinson's Disease
Neurologic drug prices jump 50% in five yearsMarch 16, 2021Business of MedicineEpilepsy & SeizuresMultiple SclerosisParkinson's Disease
Neurologic disorders ubiquitous and rising in the U.S.March 2, 2021Alzheimer's & CognitionEpilepsy & SeizuresHeadache & MigraineMovement DisordersMultiple SclerosisNeuromuscular DisordersParkinson's Disease
Ultrasound ablation for Parkinson’s disease: Benefit limited by adverse effectsJanuary 7, 2021Parkinson's DiseaseMovement Disorders
Concussion linked to risk for dementia, Parkinson’s disease, and ADHDNovember 24, 2020Traumatic Brain InjuryParkinson's DiseaseAlzheimer's & Cognition
Sublingual apomorphine alleviates off episodes in Parkinson’s diseaseNovember 3, 2020Parkinson's DiseaseMovement Disorders
Prodrug infusion beats oral Parkinson’s disease therapy for motor symptomsOctober 15, 2020Parkinson's DiseaseMovement Disorders
Telemedicine feasible and reliable in Parkinson’s trialOctober 8, 2020Parkinson's DiseaseMovement Disorders
Blood biomarker may predict Parkinson’s disease progressionSeptember 10, 2020Parkinson's DiseaseMovement Disorders
Are aging physicians a burden?August 19, 2020Alzheimer's & CognitionParkinson's DiseaseMixed TopicsBusiness of Medicine
Concussion linked to risk for dementia, Parkinson’s disease, and ADHDAugust 12, 2020Traumatic Brain InjuryParkinson's DiseaseAlzheimer's & Cognition
Can DBS in early Parkinson’s disease reduce disease progression?July 8, 2020Parkinson's DiseaseMovement Disorders
